146 related articles for article (PubMed ID: 26420819)
1. Rac1 GTPase in pancreatic cancer.
Yan Y; Ouellette MM
Aging (Albany NY); 2015 Sep; 7(9):609-10. PubMed ID: 26420819
[No Abstract] [Full Text] [Related]
2. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
3. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.
Tod J; Hanley CJ; Morgan MR; Rucka M; Mellows T; Lopez MA; Kiely P; Moutasim KA; Frampton SJ; Sabnis D; Fine DR; Johnson C; Marshall JF; Scita G; Jenei V; Thomas GJ
J Pathol; 2017 Sep; 243(1):37-50. PubMed ID: 28608476
[TBL] [Abstract][Full Text] [Related]
4. Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer.
Du J; Liu J; Smith BJ; Tsao MS; Cullen JJ
Cancer Gene Ther; 2011 Feb; 18(2):135-43. PubMed ID: 21037555
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.
Yan Y; Hein AL; Etekpo A; Burchett KM; Lin C; Enke CA; Batra SK; Cowan KH; Ouellette MM
Oncotarget; 2014 Nov; 5(21):10251-70. PubMed ID: 25344910
[TBL] [Abstract][Full Text] [Related]
6. BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Taniuchi K; Yokotani K; Saibara T
Neoplasia; 2012 May; 14(5):440-50. PubMed ID: 22745590
[TBL] [Abstract][Full Text] [Related]
7. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
8. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
9. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
10. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
Saponara E; Visentin M; Baschieri F; Seleznik G; Martinelli P; Esposito I; Buschmann J; Chen R; Parrotta R; Borgeaud N; Bombardo M; Malagola E; Caflisch A; Farhan H; Graf R; Sonda S
J Pathol; 2018 Nov; 246(3):352-365. PubMed ID: 30058725
[TBL] [Abstract][Full Text] [Related]
11. RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation.
Yan Y; Greer PM; Cao PT; Kolb RH; Cowan KH
Breast Cancer Res; 2012 Apr; 14(2):R60. PubMed ID: 22494620
[TBL] [Abstract][Full Text] [Related]
12. Rac1 in the driver's seat for melanoma.
Machesky LM; Sansom OJ
Pigment Cell Melanoma Res; 2012 Nov; 25(6):762-4. PubMed ID: 22882909
[No Abstract] [Full Text] [Related]
13. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
[TBL] [Abstract][Full Text] [Related]
14. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.
Beausoleil E; Chauvignac C; Taverne T; Lacombe S; Pognante L; Leblond B; Pallares D; Oliveira CD; Bachelot F; Carton R; Peillon H; Coutadeur S; Picard V; Lambeng N; Désiré L; Schweighoffer F
Bioorg Med Chem Lett; 2009 Oct; 19(19):5594-8. PubMed ID: 19716293
[TBL] [Abstract][Full Text] [Related]
16. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC).
Skvortsov S; Dudás J; Eichberger P; Witsch-Baumgartner M; Loeffler-Ragg J; Pritz C; Schartinger VH; Maier H; Hall J; Debbage P; Riechelmann H; Lukas P; Skvortsova I;
Br J Cancer; 2014 May; 110(11):2677-87. PubMed ID: 24786604
[TBL] [Abstract][Full Text] [Related]
17. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.
Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL
Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799
[TBL] [Abstract][Full Text] [Related]
18. Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway.
Zhang M; Ding G; Zhou L; Shen T; Xu X; Zhao T; Jia S; Cao L
J Interferon Cytokine Res; 2018 Sep; 38(9):413-422. PubMed ID: 30192158
[TBL] [Abstract][Full Text] [Related]
19. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
20. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.
Way D; Smith S; Sivendran S; Chie L; Kanovsky M; Brandt-Rauf PW; Chung DL; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2002 Jun; 49(6):429-37. PubMed ID: 12107546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
